Evernorth announces biosimilar Humira available at $0 out-of-pocket for Accredo patients in June
There will be interchangeable high and low concentration biosimilars, estimated to save individual patients $3,500 on average per year The price of biosimilars will be approximately 85% lower than Humira* …